nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—Scavenging of heme from plasma—LRP1—Alzheimer's disease	0.00433	0.0512	CbGpPWpGaD
Gatifloxacin—ALB—HDL-mediated lipid transport—A2M—Alzheimer's disease	0.00332	0.0393	CbGpPWpGaD
Gatifloxacin—ALB—Bile acid and bile salt metabolism—CYP46A1—Alzheimer's disease	0.00298	0.0352	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—SERPINA3—Alzheimer's disease	0.00287	0.0339	CbGpPWpGaD
Gatifloxacin—ALB—FOXA2 and FOXA3 transcription factor networks—TTR—Alzheimer's disease	0.00263	0.0311	CbGpPWpGaD
Gatifloxacin—ALB—Transport of vitamins, nucleosides, and related molecules—APOD—Alzheimer's disease	0.00252	0.0298	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—SERPINA3—Alzheimer's disease	0.00233	0.0276	CbGpPWpGaD
Gatifloxacin—ALB—HDL-mediated lipid transport—ABCA1—Alzheimer's disease	0.0023	0.0273	CbGpPWpGaD
Gatifloxacin—Bronchospasm—Memantine—Alzheimer's disease	0.00219	0.00239	CcSEcCtD
Gatifloxacin—Pancreatitis—Memantine—Alzheimer's disease	0.00218	0.00239	CcSEcCtD
Gatifloxacin—Dysphagia—Rivastigmine—Alzheimer's disease	0.00218	0.00238	CcSEcCtD
Gatifloxacin—Flatulence—Galantamine—Alzheimer's disease	0.00217	0.00238	CcSEcCtD
Gatifloxacin—Tension—Galantamine—Alzheimer's disease	0.00217	0.00237	CcSEcCtD
Gatifloxacin—Dysgeusia—Galantamine—Alzheimer's disease	0.00216	0.00236	CcSEcCtD
Gatifloxacin—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00214	0.00234	CcSEcCtD
Gatifloxacin—Nervousness—Galantamine—Alzheimer's disease	0.00214	0.00234	CcSEcCtD
Gatifloxacin—Pancreatitis—Rivastigmine—Alzheimer's disease	0.00214	0.00233	CcSEcCtD
Gatifloxacin—Back pain—Galantamine—Alzheimer's disease	0.00213	0.00233	CcSEcCtD
Gatifloxacin—Conjunctivitis—Donepezil—Alzheimer's disease	0.00213	0.00232	CcSEcCtD
Gatifloxacin—Muscle spasms—Galantamine—Alzheimer's disease	0.00212	0.00232	CcSEcCtD
Gatifloxacin—Sweating—Donepezil—Alzheimer's disease	0.0021	0.00229	CcSEcCtD
Gatifloxacin—Haematuria—Donepezil—Alzheimer's disease	0.00209	0.00228	CcSEcCtD
Gatifloxacin—Dysuria—Memantine—Alzheimer's disease	0.00208	0.00228	CcSEcCtD
Gatifloxacin—Neutropenia—Memantine—Alzheimer's disease	0.00208	0.00228	CcSEcCtD
Gatifloxacin—Vision blurred—Galantamine—Alzheimer's disease	0.00208	0.00227	CcSEcCtD
Gatifloxacin—Tremor—Galantamine—Alzheimer's disease	0.00207	0.00226	CcSEcCtD
Gatifloxacin—Epistaxis—Donepezil—Alzheimer's disease	0.00206	0.00225	CcSEcCtD
Gatifloxacin—Dysuria—Rivastigmine—Alzheimer's disease	0.00204	0.00223	CcSEcCtD
Gatifloxacin—Agitation—Galantamine—Alzheimer's disease	0.00203	0.00221	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Memantine—Alzheimer's disease	0.00201	0.0022	CcSEcCtD
Gatifloxacin—Bradycardia—Donepezil—Alzheimer's disease	0.002	0.00218	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00199	0.00217	CcSEcCtD
Gatifloxacin—Vertigo—Galantamine—Alzheimer's disease	0.00198	0.00217	CcSEcCtD
Gatifloxacin—Syncope—Galantamine—Alzheimer's disease	0.00198	0.00216	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00197	0.00215	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00197	0.00215	CcSEcCtD
Gatifloxacin—Hepatitis—Donepezil—Alzheimer's disease	0.00196	0.00215	CcSEcCtD
Gatifloxacin—Hallucination—Donepezil—Alzheimer's disease	0.00195	0.00214	CcSEcCtD
Gatifloxacin—Palpitations—Galantamine—Alzheimer's disease	0.00195	0.00213	CcSEcCtD
Gatifloxacin—Pharyngitis—Donepezil—Alzheimer's disease	0.00195	0.00213	CcSEcCtD
Gatifloxacin—Loss of consciousness—Galantamine—Alzheimer's disease	0.00194	0.00212	CcSEcCtD
Gatifloxacin—Oedema peripheral—Donepezil—Alzheimer's disease	0.00194	0.00211	CcSEcCtD
Gatifloxacin—Conjunctivitis—Memantine—Alzheimer's disease	0.00193	0.00211	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.00193	0.0021	CcSEcCtD
Gatifloxacin—Convulsion—Galantamine—Alzheimer's disease	0.00191	0.00209	CcSEcCtD
Gatifloxacin—ALB—Lipoprotein metabolism—A2M—Alzheimer's disease	0.00191	0.0226	CbGpPWpGaD
Gatifloxacin—Hypertension—Galantamine—Alzheimer's disease	0.0019	0.00208	CcSEcCtD
Gatifloxacin—Haematuria—Memantine—Alzheimer's disease	0.00189	0.00207	CcSEcCtD
Gatifloxacin—Visual impairment—Donepezil—Alzheimer's disease	0.00189	0.00207	CcSEcCtD
Gatifloxacin—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00189	0.00206	CcSEcCtD
Gatifloxacin—Chest pain—Galantamine—Alzheimer's disease	0.00188	0.00205	CcSEcCtD
Gatifloxacin—Arthralgia—Galantamine—Alzheimer's disease	0.00188	0.00205	CcSEcCtD
Gatifloxacin—Myalgia—Galantamine—Alzheimer's disease	0.00188	0.00205	CcSEcCtD
Gatifloxacin—Epistaxis—Memantine—Alzheimer's disease	0.00187	0.00205	CcSEcCtD
Gatifloxacin—Anxiety—Galantamine—Alzheimer's disease	0.00187	0.00204	CcSEcCtD
Gatifloxacin—Sweating—Rivastigmine—Alzheimer's disease	0.00186	0.00204	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—SERPINA3—Alzheimer's disease	0.00185	0.0219	CbGpPWpGaD
Gatifloxacin—Haematuria—Rivastigmine—Alzheimer's disease	0.00185	0.00202	CcSEcCtD
Gatifloxacin—Epistaxis—Rivastigmine—Alzheimer's disease	0.00183	0.002	CcSEcCtD
Gatifloxacin—Tinnitus—Donepezil—Alzheimer's disease	0.00183	0.002	CcSEcCtD
Gatifloxacin—Confusional state—Galantamine—Alzheimer's disease	0.00182	0.00198	CcSEcCtD
Gatifloxacin—Bradycardia—Memantine—Alzheimer's disease	0.00182	0.00198	CcSEcCtD
Gatifloxacin—Hepatitis—Memantine—Alzheimer's disease	0.00178	0.00195	CcSEcCtD
Gatifloxacin—Bradycardia—Rivastigmine—Alzheimer's disease	0.00178	0.00194	CcSEcCtD
Gatifloxacin—Hallucination—Memantine—Alzheimer's disease	0.00177	0.00194	CcSEcCtD
Gatifloxacin—Shock—Galantamine—Alzheimer's disease	0.00177	0.00194	CcSEcCtD
Gatifloxacin—Pharyngitis—Memantine—Alzheimer's disease	0.00177	0.00193	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00176	0.00193	CcSEcCtD
Gatifloxacin—Chills—Donepezil—Alzheimer's disease	0.00176	0.00193	CcSEcCtD
Gatifloxacin—Tachycardia—Galantamine—Alzheimer's disease	0.00176	0.00192	CcSEcCtD
Gatifloxacin—Oedema peripheral—Memantine—Alzheimer's disease	0.00176	0.00192	CcSEcCtD
Gatifloxacin—Hepatitis—Rivastigmine—Alzheimer's disease	0.00174	0.00191	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00174	0.0019	CcSEcCtD
Gatifloxacin—Hallucination—Rivastigmine—Alzheimer's disease	0.00174	0.0019	CcSEcCtD
Gatifloxacin—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00173	0.00189	CcSEcCtD
Gatifloxacin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—LRP1—Alzheimer's disease	0.00173	0.0204	CbGpPWpGaD
Gatifloxacin—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00172	0.00188	CcSEcCtD
Gatifloxacin—Visual impairment—Memantine—Alzheimer's disease	0.00172	0.00188	CcSEcCtD
Gatifloxacin—Anorexia—Galantamine—Alzheimer's disease	0.00172	0.00188	CcSEcCtD
Gatifloxacin—Erythema—Donepezil—Alzheimer's disease	0.00171	0.00187	CcSEcCtD
Gatifloxacin—Erythema multiforme—Memantine—Alzheimer's disease	0.00169	0.00184	CcSEcCtD
Gatifloxacin—Flatulence—Donepezil—Alzheimer's disease	0.00169	0.00184	CcSEcCtD
Gatifloxacin—Hypotension—Galantamine—Alzheimer's disease	0.00168	0.00184	CcSEcCtD
Gatifloxacin—Visual impairment—Rivastigmine—Alzheimer's disease	0.00168	0.00184	CcSEcCtD
Gatifloxacin—Tension—Donepezil—Alzheimer's disease	0.00168	0.00183	CcSEcCtD
Gatifloxacin—Dysgeusia—Donepezil—Alzheimer's disease	0.00167	0.00183	CcSEcCtD
Gatifloxacin—Eye disorder—Memantine—Alzheimer's disease	0.00167	0.00182	CcSEcCtD
Gatifloxacin—Tinnitus—Memantine—Alzheimer's disease	0.00166	0.00182	CcSEcCtD
Gatifloxacin—Nervousness—Donepezil—Alzheimer's disease	0.00166	0.00181	CcSEcCtD
Gatifloxacin—Back pain—Donepezil—Alzheimer's disease	0.00165	0.00181	CcSEcCtD
Gatifloxacin—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00165	0.0018	CcSEcCtD
Gatifloxacin—Muscle spasms—Donepezil—Alzheimer's disease	0.00164	0.0018	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00164	0.00179	CcSEcCtD
Gatifloxacin—Eye disorder—Rivastigmine—Alzheimer's disease	0.00163	0.00178	CcSEcCtD
Gatifloxacin—Insomnia—Galantamine—Alzheimer's disease	0.00163	0.00178	CcSEcCtD
Gatifloxacin—Tinnitus—Rivastigmine—Alzheimer's disease	0.00163	0.00178	CcSEcCtD
Gatifloxacin—Paraesthesia—Galantamine—Alzheimer's disease	0.00162	0.00177	CcSEcCtD
Gatifloxacin—Vision blurred—Donepezil—Alzheimer's disease	0.00161	0.00176	CcSEcCtD
Gatifloxacin—Tremor—Donepezil—Alzheimer's disease	0.0016	0.00175	CcSEcCtD
Gatifloxacin—Somnolence—Galantamine—Alzheimer's disease	0.0016	0.00175	CcSEcCtD
Gatifloxacin—Chills—Memantine—Alzheimer's disease	0.0016	0.00175	CcSEcCtD
Gatifloxacin—Dyspepsia—Galantamine—Alzheimer's disease	0.00159	0.00173	CcSEcCtD
Gatifloxacin—Agitation—Donepezil—Alzheimer's disease	0.00157	0.00172	CcSEcCtD
Gatifloxacin—Chills—Rivastigmine—Alzheimer's disease	0.00157	0.00171	CcSEcCtD
Gatifloxacin—Decreased appetite—Galantamine—Alzheimer's disease	0.00157	0.00171	CcSEcCtD
Gatifloxacin—Constipation—Galantamine—Alzheimer's disease	0.00154	0.00168	CcSEcCtD
Gatifloxacin—Vertigo—Donepezil—Alzheimer's disease	0.00154	0.00168	CcSEcCtD
Gatifloxacin—Syncope—Donepezil—Alzheimer's disease	0.00153	0.00168	CcSEcCtD
Gatifloxacin—Flatulence—Memantine—Alzheimer's disease	0.00153	0.00167	CcSEcCtD
Gatifloxacin—Tension—Memantine—Alzheimer's disease	0.00152	0.00166	CcSEcCtD
Gatifloxacin—Dysgeusia—Memantine—Alzheimer's disease	0.00152	0.00166	CcSEcCtD
Gatifloxacin—Erythema—Rivastigmine—Alzheimer's disease	0.00152	0.00166	CcSEcCtD
Gatifloxacin—ALB—HDL-mediated lipid transport—APOE—Alzheimer's disease	0.00152	0.0179	CbGpPWpGaD
Gatifloxacin—Nervousness—Memantine—Alzheimer's disease	0.00151	0.00165	CcSEcCtD
Gatifloxacin—Loss of consciousness—Donepezil—Alzheimer's disease	0.0015	0.00164	CcSEcCtD
Gatifloxacin—Back pain—Memantine—Alzheimer's disease	0.0015	0.00164	CcSEcCtD
Gatifloxacin—Flatulence—Rivastigmine—Alzheimer's disease	0.0015	0.00163	CcSEcCtD
Gatifloxacin—Tension—Rivastigmine—Alzheimer's disease	0.00149	0.00163	CcSEcCtD
Gatifloxacin—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00149	0.00162	CcSEcCtD
Gatifloxacin—Feeling abnormal—Galantamine—Alzheimer's disease	0.00148	0.00162	CcSEcCtD
Gatifloxacin—Convulsion—Donepezil—Alzheimer's disease	0.00148	0.00162	CcSEcCtD
Gatifloxacin—Hypertension—Donepezil—Alzheimer's disease	0.00148	0.00161	CcSEcCtD
Gatifloxacin—Nervousness—Rivastigmine—Alzheimer's disease	0.00148	0.00161	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00147	0.00161	CcSEcCtD
Gatifloxacin—Back pain—Rivastigmine—Alzheimer's disease	0.00147	0.0016	CcSEcCtD
Gatifloxacin—Vision blurred—Memantine—Alzheimer's disease	0.00146	0.0016	CcSEcCtD
Gatifloxacin—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00146	0.0016	CcSEcCtD
Gatifloxacin—Arthralgia—Donepezil—Alzheimer's disease	0.00146	0.00159	CcSEcCtD
Gatifloxacin—Myalgia—Donepezil—Alzheimer's disease	0.00146	0.00159	CcSEcCtD
Gatifloxacin—Chest pain—Donepezil—Alzheimer's disease	0.00146	0.00159	CcSEcCtD
Gatifloxacin—Tremor—Memantine—Alzheimer's disease	0.00145	0.00159	CcSEcCtD
Gatifloxacin—Anxiety—Donepezil—Alzheimer's disease	0.00145	0.00158	CcSEcCtD
Gatifloxacin—Vision blurred—Rivastigmine—Alzheimer's disease	0.00143	0.00156	CcSEcCtD
Gatifloxacin—Agitation—Memantine—Alzheimer's disease	0.00143	0.00156	CcSEcCtD
Gatifloxacin—Body temperature increased—Galantamine—Alzheimer's disease	0.00142	0.00156	CcSEcCtD
Gatifloxacin—Abdominal pain—Galantamine—Alzheimer's disease	0.00142	0.00156	CcSEcCtD
Gatifloxacin—Tremor—Rivastigmine—Alzheimer's disease	0.00142	0.00155	CcSEcCtD
Gatifloxacin—Confusional state—Donepezil—Alzheimer's disease	0.00141	0.00154	CcSEcCtD
Gatifloxacin—Agitation—Rivastigmine—Alzheimer's disease	0.0014	0.00152	CcSEcCtD
Gatifloxacin—Oedema—Donepezil—Alzheimer's disease	0.0014	0.00152	CcSEcCtD
Gatifloxacin—Vertigo—Memantine—Alzheimer's disease	0.00139	0.00152	CcSEcCtD
Gatifloxacin—Syncope—Memantine—Alzheimer's disease	0.00139	0.00152	CcSEcCtD
Gatifloxacin—Infection—Donepezil—Alzheimer's disease	0.00139	0.00151	CcSEcCtD
Gatifloxacin—Shock—Donepezil—Alzheimer's disease	0.00137	0.0015	CcSEcCtD
Gatifloxacin—Palpitations—Memantine—Alzheimer's disease	0.00137	0.0015	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00137	0.00149	CcSEcCtD
Gatifloxacin—Vertigo—Rivastigmine—Alzheimer's disease	0.00136	0.00149	CcSEcCtD
Gatifloxacin—Loss of consciousness—Memantine—Alzheimer's disease	0.00136	0.00149	CcSEcCtD
Gatifloxacin—Syncope—Rivastigmine—Alzheimer's disease	0.00136	0.00149	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00135	0.00147	CcSEcCtD
Gatifloxacin—Convulsion—Memantine—Alzheimer's disease	0.00135	0.00147	CcSEcCtD
Gatifloxacin—Palpitations—Rivastigmine—Alzheimer's disease	0.00134	0.00147	CcSEcCtD
Gatifloxacin—Hypertension—Memantine—Alzheimer's disease	0.00134	0.00146	CcSEcCtD
Gatifloxacin—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00133	0.00146	CcSEcCtD
Gatifloxacin—Anorexia—Donepezil—Alzheimer's disease	0.00133	0.00145	CcSEcCtD
Gatifloxacin—Hypersensitivity—Galantamine—Alzheimer's disease	0.00133	0.00145	CcSEcCtD
Gatifloxacin—ALB—Lipoprotein metabolism—ABCA1—Alzheimer's disease	0.00132	0.0157	CbGpPWpGaD
Gatifloxacin—Arthralgia—Memantine—Alzheimer's disease	0.00132	0.00144	CcSEcCtD
Gatifloxacin—Myalgia—Memantine—Alzheimer's disease	0.00132	0.00144	CcSEcCtD
Gatifloxacin—Chest pain—Memantine—Alzheimer's disease	0.00132	0.00144	CcSEcCtD
Gatifloxacin—Anxiety—Memantine—Alzheimer's disease	0.00132	0.00144	CcSEcCtD
Gatifloxacin—Convulsion—Rivastigmine—Alzheimer's disease	0.00132	0.00144	CcSEcCtD
Gatifloxacin—Hypertension—Rivastigmine—Alzheimer's disease	0.00131	0.00143	CcSEcCtD
Gatifloxacin—Hypotension—Donepezil—Alzheimer's disease	0.0013	0.00142	CcSEcCtD
Gatifloxacin—Arthralgia—Rivastigmine—Alzheimer's disease	0.00129	0.00141	CcSEcCtD
Gatifloxacin—Myalgia—Rivastigmine—Alzheimer's disease	0.00129	0.00141	CcSEcCtD
Gatifloxacin—Chest pain—Rivastigmine—Alzheimer's disease	0.00129	0.00141	CcSEcCtD
Gatifloxacin—Asthenia—Galantamine—Alzheimer's disease	0.00129	0.00141	CcSEcCtD
Gatifloxacin—Anxiety—Rivastigmine—Alzheimer's disease	0.00129	0.00141	CcSEcCtD
Gatifloxacin—Confusional state—Memantine—Alzheimer's disease	0.00128	0.0014	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00127	0.00139	CcSEcCtD
Gatifloxacin—ALB—Lipid and lipoprotein metabolism—A2M—Alzheimer's disease	0.00127	0.015	CbGpPWpGaD
Gatifloxacin—Oedema—Memantine—Alzheimer's disease	0.00127	0.00138	CcSEcCtD
Gatifloxacin—Insomnia—Donepezil—Alzheimer's disease	0.00126	0.00138	CcSEcCtD
Gatifloxacin—Infection—Memantine—Alzheimer's disease	0.00126	0.00138	CcSEcCtD
Gatifloxacin—Paraesthesia—Donepezil—Alzheimer's disease	0.00125	0.00137	CcSEcCtD
Gatifloxacin—Confusional state—Rivastigmine—Alzheimer's disease	0.00125	0.00137	CcSEcCtD
Gatifloxacin—Shock—Memantine—Alzheimer's disease	0.00125	0.00136	CcSEcCtD
Gatifloxacin—Dyspnoea—Donepezil—Alzheimer's disease	0.00124	0.00136	CcSEcCtD
Gatifloxacin—Somnolence—Donepezil—Alzheimer's disease	0.00124	0.00136	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Memantine—Alzheimer's disease	0.00124	0.00136	CcSEcCtD
Gatifloxacin—Oedema—Rivastigmine—Alzheimer's disease	0.00124	0.00135	CcSEcCtD
Gatifloxacin—Tachycardia—Memantine—Alzheimer's disease	0.00124	0.00135	CcSEcCtD
Gatifloxacin—Diarrhoea—Galantamine—Alzheimer's disease	0.00123	0.00135	CcSEcCtD
Gatifloxacin—Infection—Rivastigmine—Alzheimer's disease	0.00123	0.00135	CcSEcCtD
Gatifloxacin—Dyspepsia—Donepezil—Alzheimer's disease	0.00123	0.00134	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Memantine—Alzheimer's disease	0.00122	0.00134	CcSEcCtD
Gatifloxacin—Shock—Rivastigmine—Alzheimer's disease	0.00122	0.00133	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00121	0.00133	CcSEcCtD
Gatifloxacin—Decreased appetite—Donepezil—Alzheimer's disease	0.00121	0.00133	CcSEcCtD
Gatifloxacin—Tachycardia—Rivastigmine—Alzheimer's disease	0.00121	0.00132	CcSEcCtD
Gatifloxacin—Anorexia—Memantine—Alzheimer's disease	0.00121	0.00132	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.0012	0.00131	CcSEcCtD
Gatifloxacin—Constipation—Donepezil—Alzheimer's disease	0.00119	0.0013	CcSEcCtD
Gatifloxacin—Dizziness—Galantamine—Alzheimer's disease	0.00119	0.0013	CcSEcCtD
Gatifloxacin—Hypotension—Memantine—Alzheimer's disease	0.00118	0.00129	CcSEcCtD
Gatifloxacin—Anorexia—Rivastigmine—Alzheimer's disease	0.00118	0.00129	CcSEcCtD
Gatifloxacin—Hypotension—Rivastigmine—Alzheimer's disease	0.00116	0.00127	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00115	0.00126	CcSEcCtD
Gatifloxacin—Feeling abnormal—Donepezil—Alzheimer's disease	0.00115	0.00126	CcSEcCtD
Gatifloxacin—Insomnia—Memantine—Alzheimer's disease	0.00115	0.00125	CcSEcCtD
Gatifloxacin—Vomiting—Galantamine—Alzheimer's disease	0.00114	0.00125	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00114	0.00125	CcSEcCtD
Gatifloxacin—Paraesthesia—Memantine—Alzheimer's disease	0.00114	0.00124	CcSEcCtD
Gatifloxacin—Rash—Galantamine—Alzheimer's disease	0.00114	0.00124	CcSEcCtD
Gatifloxacin—Dermatitis—Galantamine—Alzheimer's disease	0.00113	0.00124	CcSEcCtD
Gatifloxacin—Dyspnoea—Memantine—Alzheimer's disease	0.00113	0.00123	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00113	0.00123	CcSEcCtD
Gatifloxacin—Headache—Galantamine—Alzheimer's disease	0.00113	0.00123	CcSEcCtD
Gatifloxacin—Somnolence—Memantine—Alzheimer's disease	0.00113	0.00123	CcSEcCtD
Gatifloxacin—Insomnia—Rivastigmine—Alzheimer's disease	0.00112	0.00122	CcSEcCtD
Gatifloxacin—Dyspepsia—Memantine—Alzheimer's disease	0.00112	0.00122	CcSEcCtD
Gatifloxacin—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00111	0.00122	CcSEcCtD
Gatifloxacin—Urticaria—Donepezil—Alzheimer's disease	0.00111	0.00121	CcSEcCtD
Gatifloxacin—ALB—Vitamin B12 Metabolism—MPO—Alzheimer's disease	0.00111	0.0131	CbGpPWpGaD
Gatifloxacin—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00111	0.00121	CcSEcCtD
Gatifloxacin—Body temperature increased—Donepezil—Alzheimer's disease	0.0011	0.00121	CcSEcCtD
Gatifloxacin—Abdominal pain—Donepezil—Alzheimer's disease	0.0011	0.00121	CcSEcCtD
Gatifloxacin—Somnolence—Rivastigmine—Alzheimer's disease	0.0011	0.0012	CcSEcCtD
Gatifloxacin—Decreased appetite—Memantine—Alzheimer's disease	0.0011	0.0012	CcSEcCtD
Gatifloxacin—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00109	0.00119	CcSEcCtD
Gatifloxacin—Constipation—Memantine—Alzheimer's disease	0.00108	0.00118	CcSEcCtD
Gatifloxacin—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00108	0.00118	CcSEcCtD
Gatifloxacin—Nausea—Galantamine—Alzheimer's disease	0.00107	0.00117	CcSEcCtD
Gatifloxacin—Constipation—Rivastigmine—Alzheimer's disease	0.00106	0.00116	CcSEcCtD
Gatifloxacin—Feeling abnormal—Memantine—Alzheimer's disease	0.00104	0.00114	CcSEcCtD
Gatifloxacin—ALB—Lipoprotein metabolism—LPL—Alzheimer's disease	0.00104	0.0123	CbGpPWpGaD
Gatifloxacin—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00104	0.00113	CcSEcCtD
Gatifloxacin—Hypersensitivity—Donepezil—Alzheimer's disease	0.00103	0.00112	CcSEcCtD
Gatifloxacin—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00102	0.00112	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00101	0.00111	CcSEcCtD
Gatifloxacin—Urticaria—Memantine—Alzheimer's disease	0.00101	0.0011	CcSEcCtD
Gatifloxacin—Abdominal pain—Memantine—Alzheimer's disease	0.001	0.00109	CcSEcCtD
Gatifloxacin—Body temperature increased—Memantine—Alzheimer's disease	0.001	0.00109	CcSEcCtD
Gatifloxacin—Asthenia—Donepezil—Alzheimer's disease	0.001	0.00109	CcSEcCtD
Gatifloxacin—Pruritus—Donepezil—Alzheimer's disease	0.000987	0.00108	CcSEcCtD
Gatifloxacin—Urticaria—Rivastigmine—Alzheimer's disease	0.000985	0.00108	CcSEcCtD
Gatifloxacin—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00098	0.00107	CcSEcCtD
Gatifloxacin—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00098	0.00107	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—CLU—Alzheimer's disease	0.000978	0.0116	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Donepezil—Alzheimer's disease	0.000955	0.00104	CcSEcCtD
Gatifloxacin—Hypersensitivity—Memantine—Alzheimer's disease	0.000934	0.00102	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—CLU—Alzheimer's disease	0.000931	0.011	CbGpPWpGaD
Gatifloxacin—Dizziness—Donepezil—Alzheimer's disease	0.000923	0.00101	CcSEcCtD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC24A4—Alzheimer's disease	0.000917	0.0108	CbGpPWpGaD
Gatifloxacin—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000913	0.000998	CcSEcCtD
Gatifloxacin—Asthenia—Memantine—Alzheimer's disease	0.000909	0.000993	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—MPO—Alzheimer's disease	0.0009	0.0106	CbGpPWpGaD
Gatifloxacin—Pruritus—Memantine—Alzheimer's disease	0.000897	0.000979	CcSEcCtD
Gatifloxacin—Asthenia—Rivastigmine—Alzheimer's disease	0.000889	0.000972	CcSEcCtD
Gatifloxacin—Vomiting—Donepezil—Alzheimer's disease	0.000887	0.000969	CcSEcCtD
Gatifloxacin—Rash—Donepezil—Alzheimer's disease	0.00088	0.000961	CcSEcCtD
Gatifloxacin—ALB—Lipid and lipoprotein metabolism—ABCA1—Alzheimer's disease	0.00088	0.0104	CbGpPWpGaD
Gatifloxacin—Dermatitis—Donepezil—Alzheimer's disease	0.000879	0.00096	CcSEcCtD
Gatifloxacin—Pruritus—Rivastigmine—Alzheimer's disease	0.000877	0.000958	CcSEcCtD
Gatifloxacin—Headache—Donepezil—Alzheimer's disease	0.000874	0.000955	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—A2M—Alzheimer's disease	0.000871	0.0103	CbGpPWpGaD
Gatifloxacin—ALB—Lipoprotein metabolism—APOE—Alzheimer's disease	0.000871	0.0103	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Memantine—Alzheimer's disease	0.000867	0.000947	CcSEcCtD
Gatifloxacin—ALB—Vitamin B12 Metabolism—ABCA1—Alzheimer's disease	0.000866	0.0102	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000848	0.000927	CcSEcCtD
Gatifloxacin—Dizziness—Memantine—Alzheimer's disease	0.000838	0.000915	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—A2M—Alzheimer's disease	0.00083	0.00982	CbGpPWpGaD
Gatifloxacin—Nausea—Donepezil—Alzheimer's disease	0.000829	0.000906	CcSEcCtD
Gatifloxacin—Dizziness—Rivastigmine—Alzheimer's disease	0.00082	0.000895	CcSEcCtD
Gatifloxacin—Vomiting—Memantine—Alzheimer's disease	0.000806	0.00088	CcSEcCtD
Gatifloxacin—Rash—Memantine—Alzheimer's disease	0.000799	0.000873	CcSEcCtD
Gatifloxacin—Dermatitis—Memantine—Alzheimer's disease	0.000798	0.000872	CcSEcCtD
Gatifloxacin—Headache—Memantine—Alzheimer's disease	0.000794	0.000867	CcSEcCtD
Gatifloxacin—Vomiting—Rivastigmine—Alzheimer's disease	0.000788	0.000861	CcSEcCtD
Gatifloxacin—Rash—Rivastigmine—Alzheimer's disease	0.000782	0.000854	CcSEcCtD
Gatifloxacin—Dermatitis—Rivastigmine—Alzheimer's disease	0.000781	0.000853	CcSEcCtD
Gatifloxacin—Headache—Rivastigmine—Alzheimer's disease	0.000777	0.000848	CcSEcCtD
Gatifloxacin—ALB—Vitamin B12 Metabolism—SOD1—Alzheimer's disease	0.000772	0.00913	CbGpPWpGaD
Gatifloxacin—Nausea—Memantine—Alzheimer's disease	0.000753	0.000822	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—TF—Alzheimer's disease	0.000741	0.00876	CbGpPWpGaD
Gatifloxacin—Nausea—Rivastigmine—Alzheimer's disease	0.000736	0.000804	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—MPO—Alzheimer's disease	0.000715	0.00846	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—TF—Alzheimer's disease	0.000706	0.00835	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—ABCA1—Alzheimer's disease	0.000704	0.00833	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—SOD2—Alzheimer's disease	0.000695	0.00822	CbGpPWpGaD
Gatifloxacin—ALB—Lipid and lipoprotein metabolism—LPL—Alzheimer's disease	0.00069	0.00816	CbGpPWpGaD
Gatifloxacin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—Alzheimer's disease	0.000678	0.00802	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—APP—Alzheimer's disease	0.00066	0.00781	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—PTGS1—Alzheimer's disease	0.000658	0.00778	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC30A6—Alzheimer's disease	0.000636	0.00752	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—APP—Alzheimer's disease	0.000629	0.00744	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—SOD1—Alzheimer's disease	0.000628	0.00743	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—MTHFR—Alzheimer's disease	0.000612	0.00723	CbGpPWpGaD
Gatifloxacin—ALB—FOXA2 and FOXA3 transcription factor networks—F2—Alzheimer's disease	0.000604	0.00715	CbGpPWpGaD
Gatifloxacin—ALB—Lipid and lipoprotein metabolism—APOE—Alzheimer's disease	0.000579	0.00684	CbGpPWpGaD
Gatifloxacin—ALB—Lipid and lipoprotein metabolism—CAV1—Alzheimer's disease	0.000573	0.00678	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—APOE—Alzheimer's disease	0.000569	0.00674	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—SOD2—Alzheimer's disease	0.000565	0.00669	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—ABCA1—Alzheimer's disease	0.00056	0.00662	CbGpPWpGaD
Gatifloxacin—ALB—FOXA2 and FOXA3 transcription factor networks—CREB1—Alzheimer's disease	0.000551	0.00651	CbGpPWpGaD
Gatifloxacin—ALB—FOXA2 and FOXA3 transcription factor networks—INS—Alzheimer's disease	0.000547	0.00648	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—APOD—Alzheimer's disease	0.00054	0.00639	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—SOD1—Alzheimer's disease	0.000538	0.00637	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—F2—Alzheimer's disease	0.000537	0.00635	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000523	0.00618	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—Alzheimer's disease	0.000513	0.00606	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—IGF2—Alzheimer's disease	0.000511	0.00605	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—SOD1—Alzheimer's disease	0.000499	0.0059	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—MTHFR—Alzheimer's disease	0.000498	0.00589	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.00049	0.0058	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—Alzheimer's disease	0.000487	0.00576	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—INS—Alzheimer's disease	0.000486	0.00575	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—CCL2—Alzheimer's disease	0.000479	0.00566	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000466	0.00551	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—DOCK3—Alzheimer's disease	0.000458	0.00541	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—SOD2—Alzheimer's disease	0.000449	0.00531	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—PRKCG—Alzheimer's disease	0.000439	0.00519	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—F2—Alzheimer's disease	0.000437	0.00517	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—CLU—Alzheimer's disease	0.000434	0.00513	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—CALM1—Alzheimer's disease	0.000399	0.00471	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—INS—Alzheimer's disease	0.000396	0.00468	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—MTHFR—Alzheimer's disease	0.000395	0.00468	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—CCL2—Alzheimer's disease	0.000389	0.00461	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—A2M—Alzheimer's disease	0.000386	0.00457	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—CALM1—Alzheimer's disease	0.00038	0.00449	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—IL1B—Alzheimer's disease	0.000363	0.00429	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000354	0.00419	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—F2—Alzheimer's disease	0.000347	0.00411	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—CP—Alzheimer's disease	0.000339	0.00401	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—TF—Alzheimer's disease	0.000329	0.00389	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—IGF1—Alzheimer's disease	0.000328	0.00388	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000327	0.00387	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000323	0.00382	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—INS—Alzheimer's disease	0.000314	0.00372	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—Alzheimer's disease	0.000313	0.0037	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—CCL2—Alzheimer's disease	0.000309	0.00366	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—GAB2—Alzheimer's disease	0.000301	0.00355	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—IL1B—Alzheimer's disease	0.000295	0.00349	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—APP—Alzheimer's disease	0.000293	0.00346	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CDK5—Alzheimer's disease	0.000283	0.00334	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000275	0.00325	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—TNF—Alzheimer's disease	0.000263	0.00312	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—PTGS2—Alzheimer's disease	0.000252	0.00298	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—SOD1—Alzheimer's disease	0.000239	0.00282	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—IL1B—Alzheimer's disease	0.000235	0.00278	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—IGF2—Alzheimer's disease	0.000227	0.00268	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CLU—Alzheimer's disease	0.000224	0.00264	CbGpPWpGaD
Gatifloxacin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	0.000221	0.00261	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—DHCR24—Alzheimer's disease	0.000218	0.00258	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—VEGFA—Alzheimer's disease	0.000214	0.00254	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—TNF—Alzheimer's disease	0.000214	0.00253	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—IL6—Alzheimer's disease	0.000213	0.00251	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PRKCG—Alzheimer's disease	0.000204	0.00242	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—Alzheimer's disease	0.000204	0.00242	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000203	0.00241	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—A2M—Alzheimer's disease	0.000199	0.00236	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—TGFB1—Alzheimer's disease	0.000197	0.00233	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—TP53—Alzheimer's disease	0.000189	0.00223	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—Alzheimer's disease	0.000187	0.00222	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CA4—Alzheimer's disease	0.000186	0.00219	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000181	0.00214	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—CALM1—Alzheimer's disease	0.000177	0.00209	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GAPDHS—Alzheimer's disease	0.000174	0.00206	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—IL6—Alzheimer's disease	0.000173	0.00205	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000172	0.00204	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—INPP5D—Alzheimer's disease	0.000171	0.00203	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—TNF—Alzheimer's disease	0.00017	0.00201	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TF—Alzheimer's disease	0.000169	0.002	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—F2—Alzheimer's disease	0.000166	0.00197	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ATP5A1—Alzheimer's disease	0.000165	0.00196	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PLD3—Alzheimer's disease	0.000158	0.00187	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000158	0.00187	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000156	0.00184	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—GAB2—Alzheimer's disease	0.000155	0.00183	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HSD17B10—Alzheimer's disease	0.000151	0.00179	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—APP—Alzheimer's disease	0.000151	0.00179	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000148	0.00175	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000147	0.00173	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP46A1—Alzheimer's disease	0.000146	0.00172	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—IGF1—Alzheimer's disease	0.000146	0.00172	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ND1—Alzheimer's disease	0.000141	0.00166	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000137	0.00163	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—IL6—Alzheimer's disease	0.000137	0.00163	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000126	0.00149	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SOD1—Alzheimer's disease	0.000123	0.00146	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IGF2—Alzheimer's disease	0.000117	0.00138	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000108	0.00128	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PRKCG—Alzheimer's disease	0.000105	0.00125	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000103	0.00121	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	9.86e-05	0.00117	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	9.51e-05	0.00112	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PLAU—Alzheimer's disease	9.21e-05	0.00109	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CALM1—Alzheimer's disease	9.11e-05	0.00108	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—TPI1—Alzheimer's disease	9.06e-05	0.00107	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CHAT—Alzheimer's disease	9.06e-05	0.00107	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CAV1—Alzheimer's disease	9e-05	0.00106	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	8.73e-05	0.00103	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MAOB—Alzheimer's disease	8.69e-05	0.00103	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—F2—Alzheimer's disease	8.57e-05	0.00101	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—NOS2—Alzheimer's disease	8.46e-05	0.001	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GAPDH—Alzheimer's disease	8.36e-05	0.000989	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.27e-05	0.000978	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	8.19e-05	0.000969	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—A2M—Alzheimer's disease	8.08e-05	0.000955	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IGF1—Alzheimer's disease	7.51e-05	0.000888	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.2e-05	0.000852	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ACHE—Alzheimer's disease	7.03e-05	0.000831	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—INPP5D—Alzheimer's disease	6.95e-05	0.000821	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—NOS3—Alzheimer's disease	6.8e-05	0.000805	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ENO1—Alzheimer's disease	6.58e-05	0.000779	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PTGS1—Alzheimer's disease	6.58e-05	0.000779	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP2D6—Alzheimer's disease	6.46e-05	0.000764	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—BCHE—Alzheimer's disease	6.12e-05	0.000724	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	6.07e-05	0.000718	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PLCB1—Alzheimer's disease	5.78e-05	0.000683	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.67e-05	0.00067	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ABCA1—Alzheimer's disease	5.6e-05	0.000662	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—VEGFA—Alzheimer's disease	4.9e-05	0.00058	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PPARGC1A—Alzheimer's disease	4.83e-05	0.000571	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HMOX1—Alzheimer's disease	4.8e-05	0.000568	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TGFB1—Alzheimer's disease	4.5e-05	0.000532	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—LPL—Alzheimer's disease	4.39e-05	0.00052	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MTHFR—Alzheimer's disease	3.96e-05	0.000468	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TP53—Alzheimer's disease	3.7e-05	0.000438	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CALM1—Alzheimer's disease	3.7e-05	0.000437	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—APOE—Alzheimer's disease	3.68e-05	0.000436	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CAV1—Alzheimer's disease	3.65e-05	0.000432	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PPARG—Alzheimer's disease	3.21e-05	0.000379	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—INS—Alzheimer's disease	3.15e-05	0.000372	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—AKT1—Alzheimer's disease	3.13e-05	0.00037	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NOS3—Alzheimer's disease	2.76e-05	0.000326	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PTGS2—Alzheimer's disease	2.52e-05	0.000298	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AKT1—Alzheimer's disease	1.27e-05	0.00015	CbGpPWpGaD
